Status:
COMPLETED
Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome
Lead Sponsor:
Mansoura University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-36 years
Phase:
NA
Brief Summary
The purpose of this study is to compare and determine the efficacy of letrozole administration to that of combined metformin and Clomiphene in infertile women with polycystic ovary syndrome (PCOS) not...
Detailed Description
Withdrawal bleeding was achieved using 10 mg of dydrogesterone tablets for 10 days before stimulation. In the letrozole group, 2.5 mg of letrozole oral tablets (Femara; Novartis Pharma Services, Switz...
Eligibility Criteria
Inclusion
- CC resistant PCOS
Exclusion
- Congenital adrenal hyperplasia
- Cushing syndrome
- Androgen secreting tumors
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00911313
Start Date
June 1 2006
End Date
January 1 2009
Last Update
June 1 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospitals,OB/GYN department
Al Mansurah, Dakahlia Governorate, Egypt, 35511